Project Grant H8G48884

This $344,222.00 Cooperative Agreement awarded by the Centers for Disease Control and Prevention (CDC) under the Investigations and Technical Assistance program (CFDA 93.283) will support the Virginia Department of Health (VDH) in enhancing vaccine-preventable disease prevention and response efforts across the state. The project period runs from July 1, 2025 to June 30, 2030. Key objectives include bolstering immunization infrastructure, improving disease surveillance, and expanding community...

This $568,050 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the CDC Investigations and Technical Assistance program (CFDA 93.283) supports the U.S. Virgin Islands Department of Health in strengthening its Vaccines for Children program and related immunization initiatives. Key objectives include enhancing vaccination coverage, identifying underserved and vaccine-hesitant populations, and improving data quality and interoperability of the territory's...

This is a Cooperative Agreement awarded by the U.S. Centers for Disease Control and Prevention (CDC), under the Immunization Cooperative Agreements program (CFDA 93.268), to the FSM Department of Health and Social Affairs. The $1,186,841 award, effective July 1, 2025 through June 30, 2030, will support strengthening vaccine-preventable disease prevention and response efforts in the Federated States of Micronesia. The key objectives are to improve vaccination coverage rates, enhance...

This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC), under the CDC Investigations and Technical Assistance program (CFDA 93.283), aims to enhance vaccine coverage and prevent outbreaks of vaccine-preventable diseases (VPDs) in Puerto Rico. With a total funding amount of $1,400,897.00 and a period of performance from July 1, 2025 to June 30, 2030, the project will focus on three key strategies: Providing training and technical assistance to vaccine providers...

The Indiana Department of Health (IDOH) was awarded a $285,280 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283) with a project period from July 1, 2025 to June 30, 2030. This award aims to increase immunization rates, improve vaccine accessibility, and reduce disparities in Indiana through data-driven strategies and targeted outreach. Key initiatives include expanding the vaccine replacement model for...

This federal Cooperative Agreement award, provided by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) under the Immunization Cooperative Agreements program (CFDA 93.268), will provide $6,840,305 to the New York State Department of Health (NYSDOH) to support vaccine-preventable disease prevention and response efforts in New York. The project period runs from July 1, 2025, to June 30, 2030. The key products and services to be delivered through this...

This Cooperative Agreement award, valued at $871,473.00, was provided by the Centers for Disease Control and Prevention (CDC) under the Investigations and Technical Assistance program (CFDA 93.283). The award was granted to the District of Columbia Department of Health (DC Health) to support immunization efforts and reduce vaccine-preventable diseases across the District. Key objectives include enhancing immunization program infrastructure, expanding outreach, and leveraging data-driven...

The Centers for Disease Control and Prevention (CDC) awarded a $427,929 Cooperative Agreement under the CDC Investigations and Technical Assistance program (CFDA 93.283) to the Pennsylvania Department of Health (PADOH) to strengthen vaccine-preventable disease prevention and response. The award will fund the PADOH's immunization program, which includes the Bureau of Immunizations, to perform activities such as improving immunization information systems, enhancing field services, and supporting...

This $199,295 National Science Foundation project grant funded the development of a comparative online simulation tool for COVID-19 vaccine allocation strategies. Funded under the Biological Sciences program (CFDA 47.074), the Fred Hutchinson Cancer Research Center will create a mathematical model of SARS-CoV-2 transmission incorporating multiple vaccines, viral variants, and demographic factors. This model will then be used to develop a free, open-source, online comparative tool allowing up...

This Cooperative Agreement award from the Centers for Disease Control and Prevention's National Center for Immunization and Respiratory Diseases (CFDA 93.778 - Grants to States for Medicaid) provides $1,991,334 to the State of Alaska Department of Health from July 1, 2025 to June 30, 2030. The funding will support the State of Alaska's Immunization Program in improving vaccination access and coverage, reducing disparities, enhancing disease surveillance and outbreak response readiness, and...